World's Best Scientists 2026 revealed!
Clinical and Experimental Immunology
H-index 31

Clinical and Experimental Immunology

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Immunology 58 218 213 26
Medicine 1047 153 146 22

Additional Metrics

Number of Best Scientists*: 428
Documents by Best Scientists*: 336
Top 100 Ranked Scientists*: 12
SCIMAGO H-index: 162
SCIMAGO SJR: 1.308
Impact Factor: 3.8

Overview

Top Research Topics at Clinical and Experimental Immunology?

The journal mostly deals with topics like Immunology, Antibody, Antigen, Immune system and T cell. It deals with Immunology in conjunction with Internal medicine and similar fields in Endocrinology. The journal explores issues in Antibody which can be linked to other research areas like Molecular biology and Virology.

The study of Antigen encompasses disciplines such as In vitro, as well as fields such as In vivo, all of which overlap with one another. The work on Immune system addressed in the journal expands to the thematically related Immunopathology. The journal facilitates discussions on T cell that incorporate concepts from other fields like T lymphocyte, CD8 and B cell.

The studies in Cytokine featured incorporate elements of Tumor necrosis factor alpha and Inflammation, Proinflammatory cytokine. While work presented in the journal provided substantial information on Autoantibody, it also covered topics in Autoimmune disease and Autoimmunity. Specifically, studies on Interleukin 21 are prevalent in the Cytotoxic T cell works discussed.

  • Immunology (98.96%)
  • Antibody (29.26%)
  • Antigen (24.56%)

What are the most cited papers published in the journal?

  • Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD) (856 citations)
  • Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. (835 citations)
  • Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines (795 citations)

Research areas of the most cited articles at Clinical and Experimental Immunology:

The most cited papers primarily tackle Immunology, Antibody, Immune system, Antigen and Cytokine. The most cited articles address concerns in the field of Immunology by exploring it in line with topics in Internal medicine which intersect with Endocrinology subjects. The journal papers focus on Immune system but the discussions also offer insight into other areas such as Lymphocyte and Immunopathology.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Disease
  • Gene

The previous edition focused in particular on these issues:

Clinical and Experimental Immunology investigates areas of study like Immunology, Immune system, Antibody, T cell and Interleukin. The journal explores research in Internal medicine and overlapping concepts in Gastroenterology to expand the discourse in Immunology. Immune system research featured in Clinical and Experimental Immunology incorporates concerns from various other topics such as Haematopoiesis and Immunophenotyping.

The studies on Antibody discussed can also contribute to research in the domains of Rheumatoid arthritis, TIGIT and Antigen. The T cell studies discussed in Clinical and Experimental Immunology incorporate research from disciplines like

  • CD8 which is related to area like Lymphocyte,
  • Flow cytometry, which have a strong connection to Interferon.. Aside from discussions in Interleukin, it also deals with the subject of FOXP3 which intersects with IL-2 receptor disciplines.

The most cited articles from the last journal are:

  • MASP2 levels are elevated in thrombotic microangiopathies: association with microvascular endothelial cell injury and suppression by anti‐MASP2 antibody narsoplimab (10 citations)
  • Innate and adaptive immune responses to SARS-CoV-2 in humans: relevance to acquired immunity and vaccine responses. (8 citations)
  • Keratinocytes: innate immune cells in atopic dermatitis. (7 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Clinical and Experimental Immunology (based on the number of publications) are:

  • Helen Chapel (43 papers) absent at the last edition,
  • Roger Williams (34 papers) absent at the last edition,
  • Robert A. Good (33 papers) absent at the last edition,
  • Anthony P. Weetman (32 papers) absent at the last edition,
  • Hans Link (30 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Clinical and Experimental Immunology (based on the number of publications) are:

  • French Institute of Health and Medical Research (202 papers) published 2 papers at the last edition,
  • Karolinska Institutet (191 papers) absent at the last edition,
  • Imperial College London (146 papers) published 1 paper at the last edition, 2 less than at the previous edition,
  • Boston Children's Hospital (146 papers) published 6 papers at the last edition, 3 more than at the previous edition,
  • University College London (127 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 3.25% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 12.08% were posted by at least one author from the top 10 institutions publishing in the journal. Another 8.72% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 14.09% of all publications and 65.10% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases.

    D Baker;C A K Roberts;G Pryce;A S Kang

    (2020)
    190 Citations
  • Immune checkpoint inhibitor diabetes mellitus: a novel form of autoimmune diabetes.

    Zoe Quandt;Arabella Young;Mark Anderson

    (2020)
    124 Citations
  • VISTA: Coming of age as a multi‐lineage immune checkpoint

    M A ElTanbouly;E Schaafsma;R J Noelle;J L Lines

    (2020)
    95 Citations
  • Roles of cytokines and T cells in the pathogenesis of myasthenia gravis

    Akiyuki Uzawa;Satoshi Kuwabara;Shigeaki Suzuki;Tomihiro Imai

    (2021)
    91 Citations
  • Innate and adaptive immune responses to SARS-CoV-2 in humans: relevance to acquired immunity and vaccine responses.

    Stanley C. Jordan

    (2021)
    86 Citations
  • Innate immunity during SARS-CoV-2: evasion strategies and activation trigger hypoxia and vascular damage.

    S. Amor;S. Amor;L. Fernández Blanco;D. Baker

    (2020)
    84 Citations
  • Co-occurrence of IgE and IgG autoantibodies in patients with chronic spontaneous urticaria.

    R Asero;A V Marzano;A V Marzano;S Ferrucci;M Lorini

    (2020)
    76 Citations

Related Online Degrees & Career Pathways

For those interested in the medical field but seeking alternative routes, online degrees offer flexible, affordable options. Advanced practice registered nurses can advance their careers through dnp programs, which help deepen clinical expertise and leadership skills without sacrificing job commitments.

Nurses looking to enhance their qualifications can bridge their credentials via rn to bsn online cost programs. These pathways are cost-effective and designed to accommodate working professionals balancing education and practice.

If entrance exams are a concern, prospective students may explore options at top nursing school without entrance exam institutions. These programs often prioritize holistic admission criteria, easing the entry process for many aspiring nurses.

For those aiming to combine healthcare knowledge with business acumen, pursuing one of the most affordable mha programs is a strategic step. These degrees prepare students for leadership roles in healthcare management and administration, critical areas in the evolving healthcare landscape.

Best Scientists Contributing to This Journal